Net loss of Jagsonpal Pharmaceuticals reported to Rs 4.22 crore in the quarter ended June 2017 as against net profit of Rs 0.64 crore during the previous quarter ended June 2016. Sales declined 32.93% to Rs 26.90 crore in the quarter ended June 2017 as against Rs 40.11 crore during the previous quarter ended June 2016.

Powered by Capital Market - Live News

Jagsonpal Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 August 2017.

Powered by Capital Market - Live News

Net profit of Jagsonpal Pharmaceuticals declined 59.00% to Rs 0.82 crore in the quarter ended March 2017 as against Rs 2.00 crore during the previous quarter ended March 2016. Sales declined 24.56% to Rs 29.36 crore in the quarter ended March 2017 as against Rs 38.92 crore during the previous quarter ended March 2016.

For the full year,net profit rose 264.92% to Rs 11.86 crore in the year ended March 2017 as against Rs 3.25 crore during the previous year ended March 2016. Sales rose 0.26% to Rs 143.87 crore in the year ended March 2017 as against Rs 143.49 crore during the previous year ended March 2016.

Powered by Capital Market - Live News

Jagsonpal Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 28 May 2017, inter alia, have recommended the final dividend of Rs 0.1 per equity Share (i.e. 2%) , subject to the approval of the shareholders.

Powered by Capital Market - Live News